Catalog No. | HF703016 |
---|---|
Species reactivity | Human |
Applications | ELISA, Functional assay, Research in vivo |
Isotype | Human erythropoietin fragment fused via peptide linker to a Fc fragment of immunoglobulin G2 |
Expression system | Mammalian Cells |
Target | EPO, Erythropoietin, Epoetin |
Endotoxin level | Please contact the lab for this information. |
Purity | >95% purity as determined by SDS-PAGE. |
Purification | Protein A/G purified from cell culture supernatant. |
Accession | P01588 |
Form | Liquid |
Storage buffer | 0.01M PBS, pH 7.4. |
Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
Alternate Names | 2761347-19-5 |
Background | HY-P990965 is an EPOR-targeting human antibody. • Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies., PMID:33521906 • Endogenous Erythropoietin., PMID:28629524 • The Latest Evidence of Erythropoietin in the Treatment of Glaucoma., PMID:36555679 • Epoetin alfa-epbx: a new entrant into a crowded market. a historical review of the role of erythropoietin stimulating agents and the development of the first epoetin biosimilar in the United States., PMID:33307871 • Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis., PMID:30507031 • Cytoprotective effects of erythropoietin: What about the lung?, PMID:33831836 • Erythropoietin in Glaucoma: From Mechanism to Therapy., PMID:36769310 • Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties., PMID:9450795 • Erythropoietin in bone - Controversies and consensus., PMID:26822707 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
+33(0)3 90 20 54 70
19 rue de la Haye 67300 Schiltigheim France